Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Loeb

Showing results (331-340 of 355) with videos related to

Pageof 36
Sort By:
Cancers|August 10, 2024
VISTA Emerges as a Promising Target against Immune Evasion Mechanisms in MedulloblastomaNatalia Muñoz Perez, Juliana M Pensabene, Phillip M Galbo, et al.
Plos One|November 14, 2013
A novel chordoma xenograft allows in vivo drug testing and reveals the importance of NF-κB signaling in chordoma biologyMatteo M Trucco, Ola Awad, Breelyn A Wilky, et al.
Translational Oncology|July 6, 2020
Skp2 depletion reduces tumor-initiating properties and promotes apoptosis in synovial sarcomaJichuan Wang, Kenji Sato, Ed O'Donnell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2021
Therapeutic Targeting of Mesothelin with Chimeric Antigen Receptor T Cells in Acute Myeloid LeukemiaQuy Le, Sommer Castro, Thao Tang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 16, 2017
Reduced-Intensity Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Solid Tumors in Pediatric and Young Adult PatientsNicolas J Llosa, Kenneth R Cooke, Allen R Chen, et al.
Cancer|December 29, 2015
SARC009: Phase 2 study of dasatinib in patients with previously treated, high-grade, advanced sarcomaScott M Schuetze, J Kyle Wathen, David R Lucas, et al.
International Journal of Cancer|June 21, 2017
A phase II trial evaluating the feasibility of adding bevacizumab to standard osteosarcoma therapyFariba Navid, Victor M Santana, Michael Neel, et al.
Nature Communications|January 28, 2026
Cycling molecular assemblies for Golgi imaging and disruptionWeiyi Tan, Qiuxin Zhang, Zhiyu Liu, et al.
Transfusion|January 21, 2021
A multicenter report on the safety and efficacy of plerixafor based stem cell mobilization in children with malignant disordersNabanita Bhunia, Rolla Abu-Arja, Joseph R Stanek, et al.
JAMA Oncology|May 1, 2018
Association of Dasatinib With Progression-Free Survival Among Patients With Advanced Gastrointestinal Stromal Tumors Resistant to ImatinibScott M Schuetze, Vanessa Bolejack, Dafydd G Thomas, et al.
Pageof 36

Showing results (331-340 of 355) with videos related to

Sort By:
Pageof 36
Cancers|August 10, 2024
VISTA Emerges as a Promising Target against Immune Evasion Mechanisms in MedulloblastomaNatalia Muñoz Perez, Juliana M Pensabene, Phillip M Galbo, et al.
Plos One|November 14, 2013
A novel chordoma xenograft allows in vivo drug testing and reveals the importance of NF-κB signaling in chordoma biologyMatteo M Trucco, Ola Awad, Breelyn A Wilky, et al.
Translational Oncology|July 6, 2020
Skp2 depletion reduces tumor-initiating properties and promotes apoptosis in synovial sarcomaJichuan Wang, Kenji Sato, Ed O'Donnell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2021
Therapeutic Targeting of Mesothelin with Chimeric Antigen Receptor T Cells in Acute Myeloid LeukemiaQuy Le, Sommer Castro, Thao Tang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 16, 2017
Reduced-Intensity Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Solid Tumors in Pediatric and Young Adult PatientsNicolas J Llosa, Kenneth R Cooke, Allen R Chen, et al.
Cancer|December 29, 2015
SARC009: Phase 2 study of dasatinib in patients with previously treated, high-grade, advanced sarcomaScott M Schuetze, J Kyle Wathen, David R Lucas, et al.
International Journal of Cancer|June 21, 2017
A phase II trial evaluating the feasibility of adding bevacizumab to standard osteosarcoma therapyFariba Navid, Victor M Santana, Michael Neel, et al.
Nature Communications|January 28, 2026
Cycling molecular assemblies for Golgi imaging and disruptionWeiyi Tan, Qiuxin Zhang, Zhiyu Liu, et al.
Transfusion|January 21, 2021
A multicenter report on the safety and efficacy of plerixafor based stem cell mobilization in children with malignant disordersNabanita Bhunia, Rolla Abu-Arja, Joseph R Stanek, et al.
JAMA Oncology|May 1, 2018
Association of Dasatinib With Progression-Free Survival Among Patients With Advanced Gastrointestinal Stromal Tumors Resistant to ImatinibScott M Schuetze, Vanessa Bolejack, Dafydd G Thomas, et al.
Pageof 36